These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18273571)

  • 21. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]).
    Gilard M; Blanchard D; Helft G; Carrier D; Eltchaninoff H; Belle L; Finet G; Le Breton H; Boschat J;
    Am J Cardiol; 2009 Aug; 104(3):338-42. PubMed ID: 19616664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin.
    Paciaroni M; Ageno W; Agnelli G
    Thromb Haemost; 2008 May; 99(5):978-80. PubMed ID: 18449438
    [No Abstract]   [Full Text] [Related]  

  • 23. [Echo of the 2005 ACC* (2). The war of stents has started].
    Schaerlig E
    Rev Med Suisse; 2005 May; 1(20):1378, 1381. PubMed ID: 15991632
    [No Abstract]   [Full Text] [Related]  

  • 24. Self-management of oral anticoagulation reduces major outcomes in the elderly. A randomized controlled trial.
    Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U;
    Thromb Haemost; 2008 Dec; 100(6):1089-98. PubMed ID: 19132235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Almanac 2013-stable coronary artery disease.
    Islam S; Timmis A
    Anadolu Kardiyol Derg; 2014 Mar; 14(2):219-26. PubMed ID: 24573066
    [No Abstract]   [Full Text] [Related]  

  • 26. [Oral anticoagulant treatment].
    Melis Tormos E
    Rev Enferm; 2009 May; 32(5):48-54. PubMed ID: 19552155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent landmark trials in cardiology 2008.
    Jain P; Bhandari S
    Indian Heart J; 2008; 60(4):372-6. PubMed ID: 19242023
    [No Abstract]   [Full Text] [Related]  

  • 28. Differences in the safety profiles of two low-molecular-weight heparins.
    Ofosu FA
    Thromb Haemost; 2008 Jun; 99(6):989-90. PubMed ID: 18521496
    [No Abstract]   [Full Text] [Related]  

  • 29. Anticoagulants for thrombosis prophylaxis following surgery: a continuing saga.
    Caprini JA
    Thromb Haemost; 2008 Jun; 99(6):993-4. PubMed ID: 18521498
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.
    Spyropoulos AC; Douketis JD
    Int Angiol; 2008 Aug; 27(4):333-43. PubMed ID: 18677297
    [No Abstract]   [Full Text] [Related]  

  • 31. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.
    Patel MR; Dehmer GJ; Hirshfeld JW; Smith PK; Spertus JA
    Circulation; 2009 Mar; 119(9):1330-52. PubMed ID: 19131581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.
    Garcia D; Ageno W; Bussey H; Eikelboom J; Margaglione M; Marongiu F; Moia M; Palareti G; Pengo V; Poli D; Schulman S; Witt D; Wittkowksy A; Crowther M
    Am J Hematol; 2009 Sep; 84(9):579-83. PubMed ID: 19610022
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding low INR in clinical practice.
    Hylek EM; Rose AJ
    Thromb Haemost; 2009 Mar; 101(3):417-8. PubMed ID: 19277399
    [No Abstract]   [Full Text] [Related]  

  • 34. Can we reduce bleeding risk after interventional procedures?
    Hellig F
    Cardiovasc J Afr; 2021; 32(1):3-4. PubMed ID: 33646239
    [No Abstract]   [Full Text] [Related]  

  • 35. Are we ready to start outpatient treatment for pulmonary embolism?
    Meyer G
    Thromb Haemost; 2008 Nov; 100(5):736-7. PubMed ID: 18989512
    [No Abstract]   [Full Text] [Related]  

  • 36. Numerical modeling of blood damage: current status, challenges and future prospects.
    Goubergrits L
    Expert Rev Med Devices; 2006 Sep; 3(5):527-31. PubMed ID: 17064236
    [No Abstract]   [Full Text] [Related]  

  • 37. Newly diagnosed venous thromboembolism: which patients will bleed after anticoagulation is initiated?
    Goldhaber SZ
    Thromb Haemost; 2008 Jul; 100(1):5-6. PubMed ID: 18612527
    [No Abstract]   [Full Text] [Related]  

  • 38. European interventional cardiology: a global player.
    Di Mario C
    EuroIntervention; 2011 Jul; 7(3):303-6. PubMed ID: 21729831
    [No Abstract]   [Full Text] [Related]  

  • 39. Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology.
    Henderson RA; Timmis AD
    Turk Kardiyol Dern Ars; 2011 Oct; 39(7):599-610. PubMed ID: 21983774
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
    Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
    Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.